{"id":241784,"title":"Notice of Intent Published in Canada Gazette Parts I and II, December 7, 2002 and Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients: ICH Topic Q7A - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-19","captureTimestamp":"2025-04-19T05:50:19.537000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/legislation-regulatory-amendments/notice-intent-published-canada-gazette-parts-december-7-2002-good-manufacturing-practice-guidance-active-pharmaceutical-ingredients-topic.html?wbdisable=true","snippet":"Notice of Intent Published in Canada Gazette Parts I and II, December 7, 2002 and Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients: ICH Topic Q7A - Canada.ca Skip to main content Skip to \"About government\" Skip to section menu Language selection Français…","rawSnapshotUrl":"/api/snapshots/raw/241784","browseUrl":"https://replay.healtharchive.ca/job-1/20250419055019/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/legislation-regulatory-amendments/notice-intent-published-canada-gazette-parts-december-7-2002-good-manufacturing-practice-guidance-active-pharmaceutical-ingredients-topic.html?wbdisable=true#ha_snapshot=241784","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}